We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-32.59%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$186M
AUM Growth
+$37.7M
Cap. Flow
+$6.03M
Cap. Flow %
3.24%
Top 10 Hldgs %
97.73%
Holding
62
New
23
Increased
10
Reduced
8
Closed
20

Top Buys

Rank Stock Value
1
SUNE
SUNation Energy
SUNE
+$2.73M
2
EMPD
Empery Digital
EMPD
+$1.64M
3
HAO icon
Haoxi Health Technology Ltd
HAO
+$1.28M
4
HCWC
Healthy Choice Wellness
HCWC
+$954K
5
ELAB icon
Elevai Labs
ELAB
+$927K

Top Sells

Rank Stock Value
1
CORZW icon
Core Scientific Inc Tranche 1 Warrants
CORZW
+$762K
2
RDHL
Redhill Biopharma
RDHL
+$497K
3
GWAV icon
Greenwave Technology Solutions
GWAV
+$406K
4
ELTK icon
Eltek
ELTK
+$396K
5
IWM icon
iShares Russell 2000 ETF
IWM
+$304K

Sector Composition

Rank Sector Weight
1 Healthcare 2.32%
2 Technology 0.49%
3 Consumer Discretionary 0.43%
4 Consumer Staples 0.4%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRXP icon
26
NRX Pharmaceuticals
NRXP
$152M
$59.2K 0.03%
+35,049
New +$70.6K
VVOS icon
27
Vivos Therapeutics
VVOS
$5.84M
$53.5K 0.03%
+20,502
New +$53.7K
BJDX icon
28
Bluejay Diagnostics
BJDX
$1.03M
$38.8K 0.02%
+1,526
New +$109K
REVB icon
29
Revelation Biosciences
REVB
$4.06M
$36K 0.02%
+220
New +$53K
SPCB icon
30
SuperCom
SPCB
$65.9M
$35.2K 0.02%
+9,360
New +$33.5K
KPRX icon
31
Kiora Pharmaceuticals
KPRX
$11.4M
$18.3K 0.01%
+5,000
New +$19.5K
GLBS icon
32
PUT
Globus Maritime Ltd
GLBS
$60.9M
$17.5K 0.01%
91
– –
SXTPW icon
33
60 Degrees Pharmaceuticals Warrant
SXTPW
$15.5K 0.01%
271,128
-24,461
-8% -$1.41K
RVPH
34
PUT
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$13.5K 0.01%
+5
New +$111
AMPGW
35
DELISTED
Amplitech Group Warrants
AMPGW
$7.89K ﹤0.01%
197,378
-135,338
-41% -$6.32K
FMTO
36
DELISTED
Femto Technologies Inc. Common Stock
FMTO
$7.2K ﹤0.01%
+2
New +$9.13K
SCLX icon
37
PUT
Scilex Holding
SCLX
$48M
$3.98K ﹤0.01%
+1
New +$48
SCLX icon
38
Scilex Holding
SCLX
$48M
$3.72K ﹤0.01%
+115
New +$5.51K
BNKK
39
PUT
Bonk Inc
BNKK
$8.32M
$3.17K ﹤0.01%
+1
New +$35
WLDSW icon
40
Wearable Devices Ltd Warrant
WLDSW
$135K
$2.96K ﹤0.01%
207
-103
-33% -$2.18K
EFTR
41
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.29K ﹤0.01%
61,758
-290,326
-82% -$64.9K
ATOS icon
42
PUT
Atossa Therapeutics
ATOS
$24.1M
$1.37K ﹤0.01%
+1
New +$20
BNBX
43
DELISTED
BNB PLUS CORP
BNBX
– –
-94
Closed -$28.8K
APVO icon
44
Aptevo Therapeutics
APVO
$5.25M
– –
-38
Closed -$153K
BIVI icon
45
BioVie
BIVI
$10M
– –
-7,331
Closed -$294K
CHNR icon
46
China Natural Resources
CHNR
$4.54M
– –
-13,116
Closed -$82.2K
CINGW icon
47
Cingulate Inc Warrants
CINGW
$59.3K
– –
-458,522
Closed -$4.95K
CORZW icon
48
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.38B
– –
-168,974
Closed -$762K
ELTK icon
49
Eltek
ELTK
$57.7M
– –
-40,565
Closed -$396K
GEVO icon
50
CALL
Gevo
GEVO
$363M
– –
-1,258
Closed -$70.1K
1
2
3

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sabby Management held 62 positions worth $186M, up 25% from $149M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Sabby Management deployed $6.03M of net new capital in Q3 2024, opening 23 new positions and adding to 10 existing holdings. Its largest new stake was SUNation Energy: 278 shares worth $373K.

By sector, the portfolio is most concentrated in Healthcare at 2.3% of assets, down from 3.5% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Sidus Space, an estimated $145K trimmed.

  • Sabby Management's largest Q3 2024 buy was SUNation Energy: 278 shares worth $373K.
  • Sabby Management added most to Ensysce Biosciences in Q3 2024, an estimated $343K increase.
  • Sabby Management's biggest Q3 2024 reduction was Sidus Space, cutting an estimated $145K.
  • Sabby Management fully exited Core Scientific Inc Tranche 1 Warrants in Q3 2024, selling an estimated $762K.
  • Sabby Management's ten largest holdings make up 98% of its $186M portfolio in Q3 2024.
  • Sabby Management opened 23 new positions and closed 20 in Q3 2024.
  • Sabby Management's portfolio value rose 25% quarter-over-quarter to $186M.

Based on Sabby Management's 13F filing for Q3 2024, filed 14 Nov 2024.